Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 3Liver Neoplasms 2Kidney Neoplasms 2Carcinoma, Hepatocellular 2Thyroid Neoplasms 1Renal Insufficiency, Chronic 1Prostatic Neoplasms 1

Interventions

Sorafenib 52pembrolizumab 26Nivolumab 20Bevacizumab 19Radiosurgery 17Doxorubicin 12atezolizumab 9Erlotinib Hydrochloride 9lenvatinib 8cabozantinib 7Magnetic Resonance Spectroscopy 7tremelimumab 6durvalumab 6Ramucirumab 6Radiofrequency Ablation 6Cisplatin 6Sunitinib 5tislelizumab 4regorafenib 4Oxaliplatin 4Leucovorin 4Ipilimumab 4Fluorouracil 4Everolimus 4Capecitabine 4nintedanib 3fluoromisonidazole 3carotuximab 3bavituximab 3Tomography, X-Ray Computed 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Carcinoma, Hepatocellular × perflutren × Clear all
NCT02764801 2025-05-06

Contrast-enhanced Ultrasound Evaluation of Chemoembolization

Thomas Jefferson University

Phase 3 Completed
131 enrolled 10 charts
Gastrointestinal

Carcinoma, Hepatocellular

NCT02424955 2023-07-11

Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation

Stanford University

Phase NA Completed
11 enrolled 5 charts
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡